Detalles del proyecto
| Estado | Activo |
|---|---|
| Fecha de inicio/Fecha fin | 6/27/25 → 6/27/27 |
Financiación
- Alexion Pharmaceuticals: 33.385,00 US$
A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function after Kidney Transplantation
- Shah, Malay (PI)
- Rockich, Anna (CoI)